arrow
G

Gunnar Mellgren

haukeland university hospital
H指数:43
被引数:7,294

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ADAR1 Controls Macrophage Scavenging and Lipid-Buffering Programs in Metabolic Tissues

ADAR1调控代谢组织中巨噬细胞的吞噬作用和脂质缓冲程序

2026-04-260
OAAI
A Very-low-energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-day Feeding Trial (FASTOMICS-6)

极低能量快速干预增加脂肪组织炎症基因表达:一项为期6天的喂养试验(FASTOMICS-6)

2025-11-010
PRE
Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial

二甲双胍对参与随机安慰剂对照MetBreCS试验的乳腺癌幸存者转录组学和代谢组学特征的影响

2025-05-150
OA
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules
2024-08-070
PRE
Exemestane and breast cancer prevention: how low can we go? Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative dosing regimen
2024-05-020
PRE
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
2024-05-020
PRE
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort
2024-03-181
OAAI
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
2024-02-012
OAAI
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials
2024-01-262
OAAI
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation
2024-01-181
OA
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial
2023-12-012
PRE